Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00451009

Safety and Efficacy of Freezing and Thawing of Human Eggs in Assisted Reproductive Technology

Safety and Effectiveness of Freeze and Thaw Media Kits for the Manufacturing of Oocytes for Future Use in Assisted Reproductive Technology

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
ViaCell · Industry
Sex
Female
Age
21 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effectiveness of the ViaCell's product media for freezing and thawing human eggs for future use in assisted reproductive technology.

Detailed description

ViaCell's product is an investigational product intended to broaden reproductive options for women through freezing and thawing of human eggs. The egg is a large cell with a high water content, historically making it difficult to freeze. It uses a choline chloride-based media designed to protect the cells from damage during the freezing process with the goal of making it possible to successfully store and thaw eggs for future use. Following informed consent, female subjects will be screened according to the inclusion/exclusion criteria of the protocol and eligible subjects will undergo hormonal stimulation using standard IVF drugs.

Conditions

Interventions

TypeNameDescription
DEVICEViacell's product Media Kits

Timeline

Start date
2007-03-01
Completion
2009-04-01
First posted
2007-03-22
Last updated
2014-05-29

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00451009. Inclusion in this directory is not an endorsement.